Why in the World Is the Government Disrupting the Distribution of Monoclonal Antibodies Now? – PJ Media
After demonizing nearly every medication with the potential to reduce the severity of COVID-19 symptoms, the National Institutes of Health (NIH) finally recommended monoclonal antibodies earlier this summer. Before the official recommendation, some providers used them under an emergency use authorization (EUA) granted by the FDA in November 2020. The FDA just granted an EUA to allow their use for SARS-CoV-2 post-exposure and ongoing prophylaxis. This approval will increase demand.
Recently, the treatment has gotten quite a bit of media coverage. While the Department of Health and Human Services (HHS) has been promoting the treatment on the Combat Covid website since early summer, one man ensured a nationwide media campaign. Once Florida Governor Ron DeSantis decided to p...